Absolute contraindications named in the post are personal or family history of medullary thyroid carcinoma and severe pancreatic disease
J Biol Chem 2006;281:6395-6403
2017 Feb;13(2):659-665
Week 2 Symptomatic Response with Vedolizumab as a predictive factor in Japanese Anti-TNF-Naive patients with ulcerative colitis: a post hoc analysis of a randomized, placebo-controlled phase 3 Trial
Glutathione functions by inhibiting the activity of the Tyrosinase Enzyme which in turn slows down the production of Melanin responsible for the darkening of the anti-aging properties
The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease